Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Sales | 6,406,000 | 5,671,500 | 5,385,400 | 4,919,800 | 4,476,000 |
| Cost of Goods | 2,259,400 | 2,062,300 | 2,020,100 | 1,896,900 | 1,720,400 |
| Gross Profit | 4,146,600 | 3,609,200 | 3,365,300 | 3,022,900 | 2,755,600 |
| Operating Expenses | 3,093,200 | 2,641,300 | 2,353,500 | 2,083,000 | 1,796,300 |
| Operating Income | 1,053,800 | 968,200 | 1,011,900 | 940,800 | 959,700 |
| Interest Expense | 132,500 | 126,000 | 82,500 | 63,400 | 55,500 |
| Other Income | 182,000 | 74,300 | 174,400 | 133,400 | 60,700 |
| Pre-tax Income | 1,103,300 | 916,500 | 1,103,800 | 1,010,800 | 964,900 |
| Income Tax | 297,900 | 231,300 | 309,400 | 317,300 | 300,700 |
| Net Income Continuous | 801,200 | 681,100 | 791,300 | 690,200 | 660,000 |
| Net Income | $801,200 | $681,100 | $791,300 | $690,200 | $660,000 |
| EPS Basic Total Ops | 0.20 | 0.17 | 0.20 | 0.17 | 0.17 |
| EPS Basic Continuous Ops | 0.20 | 0.17 | 0.20 | 0.17 | 0.17 |
| EPS Diluted Total Ops | 0.20 | 0.17 | 0.20 | 0.17 | 0.17 |
| EPS Diluted Continuous Ops | 0.20 | 0.17 | 0.20 | 0.17 | 0.17 |
| EBITDA(a) | $1,278,600 | $1,175,300 | $1,206,400 | $1,102,800 | $1,106,800 |